Pharmacokinetic principles of bacteriophage therapy

Clinical Pharmacokinetics

Volumn 42, Issue 4, 2003, Pages 315-325

  Payne, Robert J H ^a   Jansen, Vincent A A ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIMICROBIAL THERAPY; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIOPHAGE; BACTERIOPHAGE THERAPY; DRUG EFFICACY; INOCULATION; MATHEMATICAL MODEL; MICROBIAL KINETICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; THEORY;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; BACTERIOPHAGES; BIOLOGICAL THERAPY; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HUMANS; MODELS, BIOLOGICAL;

EID: 0037255845     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-200342040-00002     Document Type: Review

References (40)

1. Sharp R. Bacteriophages: biology and history. J Chem Tech Biotechnol 2001; 76: 667-72
2. d'Herelle F. Sur un microbe invisible antagoniste des bacilles dysenteriques. C R Acad Sci 1917; 165: 373-5
3. Sulakvelidze A. Alavidze Z, Morris JG. Bacteriophage therapy. Antimicrob Agents Chemother 2001; 45: 649-59
4. Berkowitz FE. Antibiotic resistance in bacteria. South Med J 1995; 88: 797-804
5. Tenover FC, Hughes JM. The challenges of emerging infectious diseases: development and spread of multiply-resistant bacterial pathogens. JAMA 1996; 275: 300-4
6. File TM. Overview of resistance in the 1990s. Chest 1999; 115 (3 Suppl.): 3S-8S
7. Payne RJH, Jansen VAA. Phage therapy: the peculiar kinetics of self-replicating pharmaceuticals. Clin Pharmacol Ther 2000; 68: 225-9
8. Payne RJH, Jansen VAA. Understanding bacteriophage therapy as a density-dependent kinetic process. J Theor Biol 2001: 208: 37-48
9. Alisky J, Iczkowski K, Rapoport A, et al. Bacteriophage show promise as antimicrobial agents. J Infect 1998; 36: 5-15
10. Barrow PA, Soothill JS. Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential. Trends Microbiol 1997; 5: 268-71
11. Barrow PA. The use of bacteriophages for treatment of bacterial disease in animals and animal models of human infection. J Chem Tech Biotechnol 2001; 76: 677-82
12. Chanishvili N, Chanishvili T, Tediashvili M, et al. Phages and their application against drug-resistant bacteria. J Chem Tech Biotechnol 2001; 76: 689-99
13. Bacterial Ecology Group. Phage therapy references [online]. Available from: http://www.phage.org/bib_pt.htm [Accessed 2003 Jan 29]
14. Slopek S, Weber-Dabrowska B, Dabrowski M, et al. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. Arch Immunol Ther Exp (Warsz) 1987; 35: 569-83
15. Cislo M, Dabrowski M, Slopek S. Bacteriophage treatment of suppurative skin infections. Arch Immunol Ther Exp (Warsz) 1987: 35: 175-83
16. Weber-Dabrowska B, Dabrowski M, Stopek S. Studies on bacteriophage penetration in patients subjected to phage therapy. Arch Immunol Ther Exp (Warsz) 1987; 35: 563-8
17. Kucharewicz-Krukowska A, Slopek S. Immunogenic effect of bacteriophage in patients subjected to phage therapy. Arch Immunol Ther Exp (Warsz) 1987; 35: 553-61
18. Abdul-Hassan HS, El-Tahan E, Massoud B, et al. Bacteriophage therapy of Pseudomonas burn wound sepsis. Ann Medit Burn Club 1990; 3: 262-4
19. Smith HW, Huggins MB. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. J Gen Microbiol 1983; 129: 2659-75
20. Smith HW, Huggins MB, Shaw KM. The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J Gen Microbiol 1987; 133: 1111-26
21. Berchieri A, Lovell MA, Barrow PA. The activity in the chicken alimentary tract of bacteriophages lytic for Salmonella typhimurium. Res Microbiol 1991; 142: 541-9
22. Soothill JS. Treatment of experimental infection of mice with bacteriophages. J Med Microbiol 1992; 37: 258-61
23. Soothill JS. Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa. Burns 1994; 20: 209-11
24. Barrow P, Lovell M, Berchieri A. Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chicken and calves. Clin Diag Lab Immun 1998; 5: 294-8
25. Ramesh V, Fralick JA, Rolfe RD. Prevention of Clostridium difficile-induced ileocecitis with bacteriophage. Anaerobe 1999; 5: 69-78
26. Nakai T, Sugimoto R. Park KH, et al. Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail. Dis Aquat Organ 1999; 37: 33-41
27. Park SC, Shimamura I, Fukunaga M, et al. Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease control. Appl Environ Microbiol 2000; 66: 1416-22
28. Smith HW, Huggins MB. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol 1982; 128: 307-18
29. Cao J, Sun Y-Q, Berglindh T, et al. Helicobacter pylori-antigen-binding fragments expressed on the filamentous M13 phage prevent bacterial growth. Biochim Biophys Acta 2000: 1474: 107-13
30. Gotelli NJ. A primer of ecology. Sunderland (MA): Sinauer, 1998
31. Anderson RM, May RM. Infectious diseases of humans. Oxford (UK): Oxford University Press, 1992
32. Campbell A. Conditions for the existence of bacteriophage. Evolution 1961; 15: 153-65
33. Levin BR, Stewart FM, Chao L. Resource-limited growth, competition, and predation: a model and experimental studies with bacteria and bacteriophage. Am Nat 1977; 111: 3-24
34. Schrag SJ, Mittler JE. Host-parasite coexistence: the role of spatial refuges in stabilizing bacteria-phage interactions. Am Nat 1996; 148: 348-77
35. Lipsitch M, Levin BR. Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance. Int J Tuberc Lung Dis 1998; 2: 187-99
36. Slopek S, Durlakowa I, Weber-Dabrowska B, et al. Results of bacteriophage treatment of suppurative bacterial infections I: general evaluation of the results. Arch Immunol Ther Exp (Warsz) 1983; 31: 267-91
37. Sakandelidze VM. Kompleksnoe primenie spetsificheskikh fagov i antibiotikov pri razlichnykh infektsionnykh allergozakh. [The combined use of specific phages and antibiotics in different infectious allergoses] [in Russian]. Vrach Delo 1991: 3: 60-3
38. Levin BR, Bull JJ. Phage therapy revisited: the population biology of a bacterial infection and its treatment with bacteriophage and antibiotics. Am Nat 1996; 147: 881-98
39. Bull JJ, Levin BR, DeRouin T, et al. Dynamics of success and failure in phage and antibiotic therapy in experimental infections. BMC Microbiol 2002 Nov 26; 2(1): 35
40. Hawkins BA, Cornell HV, editors. Theoretical approaches to biological control. Cambridge (UK): Cambridge University Press, 1999